Abstract:Objective: The objective of this study was to conduct a meta-analysis and trial sequential analysis (TSA) of published randomized controlled trials (RCTs) to determine whether mortality benefit exists for extracorporeal blood purification techniques in sepsis. Data Sources: A systematic search on MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for RCTs was performed. Study Selection: RCTs investigating the effect of extracorporeal blood purification device use on mortality among critically ill septic patients were selected. Data Extraction: Mortality was assessed using Mantel-Haenszel models, and I 2 was used for heterogeneity. Data are presented as odds ratios (OR); 95% confidence intervals (CIs); p values; I 2 . Using the control event mortality proportion, we performed a TSA and calculated the required information size using an anticipated intervention effect of a 14% relative reduction in mortality. Data Synthesis: Thirty-nine RCTs were identified, with 2,729 patients. Fourteen studies used hemofiltration ( n = 789), 17 used endotoxin adsorption devices ( n = 1,363), 3 used nonspecific adsorption ( n = 110), 2 were cytokine removal devices ( n = 117), 2 used coupled plasma filtration adsorption (CPFA) ( n = 207), 2 combined hemofiltration and perfusion ( n = 40), and 1 used plasma exchange ( n = 106). On conventional meta-analysis, hemofiltration (OR 0.56 [0.40–0.79]; p < 0.001; I 2 = 0%), endotoxin removal devices (OR 0.40 [0.23–0.67], p < 0.001; I 2 = 71%), and nonspecific adsorption devices (OR 0.32 [0.13–0.82]; p = 0.02; I 2 = 23%) were associated with mortality benefit, but not cytokine removal (OR 0.99 [0.07–13.42], p = 0.99; I 2 = 64%), CPFA (OR 0.50 [0.10–2.47]; p = 0.40; I 2 = 64%), or combined hemofiltration and adsorption (OR 0.71 [0.13–3.79]; p = 0.69; I 2 = 0%). TSA however revealed that based on the number of existing patients recruited for RCTs, neither hemofiltration (TSA-adjusted CI 0.29–1.10), endotoxin removal devices (CI 0.05–3.40), nor nonspecific adsorption devices (CI 0.01–14.31) were associated with mortality benefit. Conclusion: There are inadequate data at present to conclude that the use of extracorporeal blood purification techniques in sepsis is beneficial. Further adequately powered RCTs are required to confirm any potential mortality benefit, which may be most evident in patients at greatest risk of death.

Rationale of Blood Purification in the Post-Resuscitation Syndrome following Out-of-Hospital Cardiac Arrest: A Narrative Review

Extracorporeal Blood Purification Therapies for Sepsis

Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials

Blood Purification Studies in the ICU: What Endpoints Should We Use?

Clinical Efficacy of Blood Purification in the Treatment of Sepsis: a Meta-Analysis of the last 5 Years

From New Hemodynamics to Blood Purification Therapies

Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis

The role of hemoadsorption in cardiac surgery – a systematic review

New Targets for Extracorporeal Blood Purification Therapies in Sepsis

Blood Purification with oXiris© in Critically Ill Children with Vasoplegic Shock

Extracorporeal Blood Purification in Burns: For Whom, Why, and How?

The clinical efficacy and suitable implementation of two extracorporeal blood purification therapies: AN69-oXiris versus PMX-HP

Sepsis Management with a Blood Purification Membrane: European Experience

Remote Postconditioning Alone and Combined with Hypothermia Improved Postresuscitation Cardiac and Neurological Outcomes in Swine.

Blood purification therapies for septic acute kidney injury

Blood purification for sepsis: an overview

Septic Hyperinflammation—Is There a Role for Extracorporeal Blood Purification Techniques?

Increased plasma disequilibrium between pro- and anti-oxidants during the early phase resuscitation after cardiac arrest is associated with increased levels of oxidative stress end-products

Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb

Hemoadsorption in Organ Preservation and Transplantation: A Narrative Review

Pyruvate as a Potential Beneficial Anion in Resuscitation Fluids